CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Participate in the Piper Sandler 36th Annual Healthcare Conference. Management holding one-on-one meetings with investors
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
November 11, 2024 07:30 ET
|
CytoSorbents; Converge Biotech
CytoSorbents and Converge Biotech Partner In India to Expand CytoSorb Blood Purification Availability to Treat Sepsis and Other Deadly Conditions
Inbiome Receives FDA Breakthrough Device Designation for Revolutionary Molecular Culture ID Technology, Transforming Bacterial Diagnostics
September 26, 2024 04:03 ET
|
inbiome
www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
BioAegis Therapeutics to Present at Upcoming MedInvest Biotech & Pharma Investor Conference in NYC
September 12, 2024 16:56 ET
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, announces that its...
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
July 17, 2024 07:00 ET
|
CytoSorbents
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
U.S. Post-Acute Market Report 2024: Post-Acute Executives Prioritize Artificial Intelligence For Workforce Management, Labor Shortages And New Federal Staffing Mandate Strain Nursing Homes
July 16, 2024 11:27 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "The 2024 U.S. Post-Acute Market Report" report has been added to ResearchAndMarkets.com's offering. The U.S. post-acute market is expected to reach...
Physician-Patient Alliance for Health and Safety Grants CME Accreditation to Second Wave of 2024 World Sepsis Spotlight Courses
June 26, 2024 10:00 ET
|
The Physician-Patient Alliance for Health & Safety
Chicago, IL, June 26, 2024 (GLOBE NEWSWIRE) -- We are pleased to announce that the remaining 4 sessions from the World Sepsis Spotlight: Unmet Need in Sepsis Diagnosis and Treatment, hosted by...
AUROBAC THERAPEUTICS APPOINTS SCIENTIFIC ADVISORY BOARD
June 20, 2024 08:00 ET
|
AUROBAC THERAPEUTICS
The newly formed Scientific Advisory Board chaired by Dr. Marco Taglietti will provide technical and strategic guidance to support AUROBAC’s R&D strategy. Lyon (France), June 20, 2024 ...
Physician-Patient Alliance for Health and Safety Grants CME Accreditation to First Wave of 2024 World Sepsis Spotlight Courses
June 11, 2024 10:00 ET
|
The Physician-Patient Alliance for Health & Safety
Physician-Patient Alliance for Health & Safety accredits first 4 sessions from the World Sepsis Spotlight: Unmet Needs in Sepsis Diagnosis and Treatment.
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...